+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Dunkin' Brands surges 18% after confirming report that it's in talks to go private for $8.8 billion

Oct 26, 2020, 18:55 IST
Business Insider
Bruce Bennett/Getty Images
  • Dunkin' Brands surged 18% on Monday after the coffee company confirmed a New York Times report that it held preliminary talks to go private in a deal worth at least $8.8 billion.
  • Inspire Brands would buy out Dunkin' for $106.50 per share, representing potential upside of 20% from Friday's close.
  • Inspire Brands is a private-equity backed firm that owns Arby's, Buffalo Wild Wings, Sonic Drive-In, and Jimmy John's.
  • "There is no certainty that any agreement will be reached," Dunkin' said in a statement.
  • Visit Business Insider's homepage for more stories.
Advertisement

Dunkin' Brands surged on Monday after the coffee-shop company confirmed a report from the New York Times that it is in preliminary discussions to be acquired for $8.8 billion by Inspire Brands.

Inspire Brands would acquire Dunkin' for $106.50 per share, according to the report, representing 20% potential upside from Friday's close.

Dunkin' surged 18% in Monday trades to just below the $106.50 offer price.

Inspire Brands is a private-equity backed firm that owns a growing portfolio of restaurant brands, including: Jimmy John's, Arby's, Sonic Drive-In, and Buffalo Wild Wings.

The potential deal, according to The New York Times, could be announced as soon as Monday.

Advertisement

"There is no certainty that any agreement will be reached," Dunkin' said in a statement.

Markets Insider

Read More: GOLDMAN SACHS: Buy these 13 unloved vaccine stocks that have the potential to spike on positive treatment updates

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article